- call +1-201-465-4211
- email sales@mrinsights.biz
Blood plasma is the liquid component of blood constituting of water along with plasma components such as immunoglobulin, electrolytes, glucose, clotting factors, electrolytes, and hormones. It plays a crucial role in maintaining the electrolyte and osmotic balance while preventing infection and blood disorders in the body. Plasma derivatives are the concentrates of specific proteins, which require pooling of plasma from large number of donors. For instance, they require more than hundred plasma donations to produce sufficient immunoglobulin to treat an immune-deficient patient for one year. They are obtained by the process of fractionation where protein concentrates are separated and then clinically used.
Scope of the Report:
This report focuses on the Blood Plasma Derivatives in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The growth of the global blood plasma derivatives market is majorly driven by increase in prevalence of life-threatening disorders, especially hemophilia. Other factors boosting the market growth include rise in adoption of blood plasma derivatives products, upsurge in geriatric population across the world, and increase in awareness about blood & plasma donation. However, factors such as high cost of plasma derivative-based therapy and post-operative risks associated with plasma replacement therapy hamper the market growth. Conversely, the development of enhanced methods for preservation of plasma derivatives along with advanced procedures for fractionation and high potential in untapped markets in the emerging economies are expected to provide lucrative growth opportunities for the market.
The worldwide market for Blood Plasma Derivatives is expected to grow at a CAGR of roughly 9.7% over the next five years, will reach 43300 million US$ in 2023, from 24800 million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Grifols, S.A.
SK Plasma Co., Ltd.
Fusion Health Care Pvt. Ltd.
Biotest AG
Green Cross Corporation
Baxter International Inc.
LFB S.A.
Octapharma AG
CSL Limited
Shire Plc.
China Biologic Products, Inc.
Kedrion Biopharma, Inc.
BDI Pharma, Inc.
Bayer AG
Hualan Biological Engineering, Inc.
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others
Market Segment by Applications, can be divided into
Hospitals
Clinics
Other End Users
There are 15 Chapters to deeply display the global Blood Plasma Derivatives market.
Chapter 1, to describe Blood Plasma Derivatives Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Blood Plasma Derivatives, with sales, revenue, and price of Blood Plasma Derivatives, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Blood Plasma Derivatives, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Blood Plasma Derivatives market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Blood Plasma Derivatives sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Blood Plasma Derivatives Introduction
1.2 Market Analysis by Type
1.2.1 Albumin
1.2.2 Factor VIII
1.2.3 Factor IX
1.2.4 Immunoglobulin
1.2.5 Hyperimmune Globulin
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Other End Users
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Grifols, S.A.
2.1.1 Business Overview
2.1.2 Blood Plasma Derivatives Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Grifols, S.A. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 SK Plasma Co., Ltd.
2.2.1 Business Overview
2.2.2 Blood Plasma Derivatives Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 SK Plasma Co., Ltd. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Fusion Health Care Pvt. Ltd.
2.3.1 Business Overview
2.3.2 Blood Plasma Derivatives Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Fusion Health Care Pvt. Ltd. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Biotest AG
2.4.1 Business Overview
2.4.2 Blood Plasma Derivatives Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Biotest AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Green Cross Corporation
2.5.1 Business Overview
2.5.2 Blood Plasma Derivatives Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Green Cross Corporation Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Baxter International Inc.
2.6.1 Business Overview
2.6.2 Blood Plasma Derivatives Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Baxter International Inc. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 LFB S.A.
2.7.1 Business Overview
2.7.2 Blood Plasma Derivatives Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LFB S.A. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Octapharma AG
2.8.1 Business Overview
2.8.2 Blood Plasma Derivatives Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Octapharma AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 CSL Limited
2.9.1 Business Overview
2.9.2 Blood Plasma Derivatives Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 CSL Limited Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Shire Plc.
2.10.1 Business Overview
2.10.2 Blood Plasma Derivatives Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Shire Plc. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 China Biologic Products, Inc.
2.11.1 Business Overview
2.11.2 Blood Plasma Derivatives Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 China Biologic Products, Inc. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Kedrion Biopharma, Inc.
2.12.1 Business Overview
2.12.2 Blood Plasma Derivatives Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Kedrion Biopharma, Inc. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 BDI Pharma, Inc.
2.13.1 Business Overview
2.13.2 Blood Plasma Derivatives Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 BDI Pharma, Inc. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Bayer AG
2.14.1 Business Overview
2.14.2 Blood Plasma Derivatives Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Bayer AG Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Hualan Biological Engineering, Inc.
2.15.1 Business Overview
2.15.2 Blood Plasma Derivatives Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Hualan Biological Engineering, Inc. Blood Plasma Derivatives Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Blood Plasma Derivatives Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Blood Plasma Derivatives Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Blood Plasma Derivatives Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Blood Plasma Derivatives Manufacturer Market Share in 2017
3.3.2 Top 6 Blood Plasma Derivatives Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Blood Plasma Derivatives Market Analysis by Regions
4.1 Global Blood Plasma Derivatives Sales, Revenue and Market Share by Regions
4.1.1 Global Blood Plasma Derivatives Sales and Market Share by Regions (2013-2018)
4.1.2 Global Blood Plasma Derivatives Revenue and Market Share by Regions (2013-2018)
4.2 North America Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
4.3 Europe Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
4.5 South America Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
5 North America Blood Plasma Derivatives by Countries
5.1 North America Blood Plasma Derivatives Sales, Revenue and Market Share by Countries
5.1.1 North America Blood Plasma Derivatives Sales and Market Share by Countries (2013-2018)
5.1.2 North America Blood Plasma Derivatives Revenue and Market Share by Countries (2013-2018)
5.2 United States Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
5.3 Canada Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
5.4 Mexico Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
6 Europe Blood Plasma Derivatives by Countries
6.1 Europe Blood Plasma Derivatives Sales, Revenue and Market Share by Countries
6.1.1 Europe Blood Plasma Derivatives Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Blood Plasma Derivatives Revenue and Market Share by Countries (2013-2018)
6.2 Germany Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
6.3 UK Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
6.4 France Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
6.5 Russia Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
6.6 Italy Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
7 Asia-Pacific Blood Plasma Derivatives by Countries
7.1 Asia-Pacific Blood Plasma Derivatives Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Blood Plasma Derivatives Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Blood Plasma Derivatives Revenue and Market Share by Countries (2013-2018)
7.2 China Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
7.3 Japan Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
7.4 Korea Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
7.5 India Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
8 South America Blood Plasma Derivatives by Countries
8.1 South America Blood Plasma Derivatives Sales, Revenue and Market Share by Countries
8.1.1 South America Blood Plasma Derivatives Sales and Market Share by Countries (2013-2018)
8.1.2 South America Blood Plasma Derivatives Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
8.3 Argentina Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
8.4 Colombia Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
9 Middle East and Africa Blood Plasma Derivatives by Countries
9.1 Middle East and Africa Blood Plasma Derivatives Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Blood Plasma Derivatives Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Blood Plasma Derivatives Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
9.3 UAE Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
9.4 Egypt Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
9.5 Nigeria Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
9.6 South Africa Blood Plasma Derivatives Sales and Growth Rate (2013-2018)
10 Global Blood Plasma Derivatives Market Segment by Type
10.1 Global Blood Plasma Derivatives Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Blood Plasma Derivatives Sales and Market Share by Type (2013-2018)
10.1.2 Global Blood Plasma Derivatives Revenue and Market Share by Type (2013-2018)
10.2 Albumin Sales Growth and Price
10.2.1 Global Albumin Sales Growth (2013-2018)
10.2.2 Global Albumin Price (2013-2018)
10.3 Factor VIII Sales Growth and Price
10.3.1 Global Factor VIII Sales Growth (2013-2018)
10.3.2 Global Factor VIII Price (2013-2018)
10.4 Factor IX Sales Growth and Price
10.4.1 Global Factor IX Sales Growth (2013-2018)
10.4.2 Global Factor IX Price (2013-2018)
10.5 Immunoglobulin Sales Growth and Price
10.5.1 Global Immunoglobulin Sales Growth (2013-2018)
10.5.2 Global Immunoglobulin Price (2013-2018)
10.6 Hyperimmune Globulin Sales Growth and Price
10.6.1 Global Hyperimmune Globulin Sales Growth (2013-2018)
10.6.2 Global Hyperimmune Globulin Price (2013-2018)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2013-2018)
10.7.2 Global Others Price (2013-2018)
11 Global Blood Plasma Derivatives Market Segment by Application
11.1 Global Blood Plasma Derivatives Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Other End Users Sales Growth (2013-2018)
12 Blood Plasma Derivatives Market Forecast (2018-2023)
12.1 Global Blood Plasma Derivatives Sales, Revenue and Growth Rate (2018-2023)
12.2 Blood Plasma Derivatives Market Forecast by Regions (2018-2023)
12.2.1 North America Blood Plasma Derivatives Market Forecast (2018-2023)
12.2.2 Europe Blood Plasma Derivatives Market Forecast (2018-2023)
12.2.3 Asia-Pacific Blood Plasma Derivatives Market Forecast (2018-2023)
12.2.4 South America Blood Plasma Derivatives Market Forecast (2018-2023)
12.2.5 Middle East and Africa Blood Plasma Derivatives Market Forecast (2018-2023)
12.3 Blood Plasma Derivatives Market Forecast by Type (2018-2023)
12.3.1 Global Blood Plasma Derivatives Sales Forecast by Type (2018-2023)
12.3.2 Global Blood Plasma Derivatives Market Share Forecast by Type (2018-2023)
12.4 Blood Plasma Derivatives Market Forecast by Application (2018-2023)
12.4.1 Global Blood Plasma Derivatives Sales Forecast by Application (2018-2023)
12.4.2 Global Blood Plasma Derivatives Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Blood Plasma Derivatives Picture
Table Product Specifications of Blood Plasma Derivatives
Figure Global Sales Market Share of Blood Plasma Derivatives by Types in 20
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
